Shanghai RAAS Blood Products Co Ltd
SZSE:002252

Watchlist Manager
Shanghai RAAS Blood Products Co Ltd Logo
Shanghai RAAS Blood Products Co Ltd
SZSE:002252
Watchlist
Price: 6.34 CNY -1.55% Market Closed
Market Cap: 42.1B CNY

Intrinsic Value

The intrinsic value of one Shanghai RAAS Blood Products Co Ltd stock under the Base Case scenario is 7.13 CNY. Compared to the current market price of 6.34 CNY, Shanghai RAAS Blood Products Co Ltd is Undervalued by 11%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
7.13 CNY
Undervaluation 11%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Shanghai RAAS Blood Products Co Ltd

What is Valuation History?
Ask AI Assistant
What other research platforms think about Shanghai RAAS Blood Products Co Ltd?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is Shanghai RAAS Blood Products Co Ltd valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Shanghai RAAS Blood Products Co Ltd.

Explain Valuation
Compare Shanghai RAAS Blood Products Co Ltd to

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about Shanghai RAAS Blood Products Co Ltd?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Shanghai RAAS Blood Products Co Ltd

Current Assets 9.9B
Cash & Short-Term Investments 4B
Receivables 2.5B
Other Current Assets 3.4B
Non-Current Assets 28.3B
Long-Term Investments 16.5B
PP&E 2.5B
Intangibles 9.1B
Other Non-Current Assets 200.6m
Current Liabilities 3.1B
Accounts Payable 1.5B
Accrued Liabilities 195.4m
Short-Term Debt 420.7m
Other Current Liabilities 969.2m
Non-Current Liabilities 2.6B
Long-Term Debt 2.5B
Other Non-Current Liabilities 139.2m
Efficiency

Free Cash Flow Analysis
Shanghai RAAS Blood Products Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Shanghai RAAS Blood Products Co Ltd

Revenue
8B CNY
Cost of Revenue
-5B CNY
Gross Profit
3B CNY
Operating Expenses
-1.2B CNY
Operating Income
1.8B CNY
Other Expenses
20.8m CNY
Net Income
1.8B CNY
Fundamental Scores

Profitability Score
Profitability Due Diligence

Shanghai RAAS Blood Products Co Ltd's profitability score is 50/100. The higher the profitability score, the more profitable the company is.

Healthy Operating Margin
Sustainable 3Y Average Operating Margin
Healthy Gross Margin
Healthy Net Margin
50/100
Profitability
Score

Shanghai RAAS Blood Products Co Ltd's profitability score is 50/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Shanghai RAAS Blood Products Co Ltd's solvency score is 80/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Long-Term Solvency
Low D/E
Short-Term Solvency
80/100
Solvency
Score

Shanghai RAAS Blood Products Co Ltd's solvency score is 80/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Shanghai RAAS Blood Products Co Ltd

Wall Street analysts forecast Shanghai RAAS Blood Products Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Shanghai RAAS Blood Products Co Ltd is 7.14 CNY with a low forecast of 6.06 CNY and a high forecast of 8.4 CNY.

Lowest
Price Target
6.06 CNY
4% Downside
Average
Price Target
7.14 CNY
13% Upside
Highest
Price Target
8.4 CNY
32% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for Shanghai RAAS Blood Products Co Ltd is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one Shanghai RAAS Blood Products Co Ltd stock?

The intrinsic value of one Shanghai RAAS Blood Products Co Ltd stock under the Base Case scenario is 7.13 CNY.

Is Shanghai RAAS Blood Products Co Ltd stock undervalued or overvalued?

Compared to the current market price of 6.34 CNY, Shanghai RAAS Blood Products Co Ltd is Undervalued by 11%.

Back to Top